18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Sebastian Zschaeck - , Charité – Universitätsmedizin Berlin (Author)
  • Julian Weingärtner - , Charité – Universitätsmedizin Berlin (Author)
  • Elia Lombardo - , University Hospital Münster (Author)
  • Sebastian Marschner - , University Hospital Münster (Author)
  • Marina Hajiyianni - , Charité – Universitätsmedizin Berlin (Author)
  • Marcus Beck - , Charité – Universitätsmedizin Berlin (Author)
  • Daniel Zips - , Charité – Universitätsmedizin Berlin (Author)
  • Yimin Li - , The First Affiliated Hospital of Xiamen University (Author)
  • Qin Lin - , The First Affiliated Hospital of Xiamen University (Author)
  • Holger Amthauer - , Charité – Universitätsmedizin Berlin (Author)
  • Esther G C Troost - , Department of Radiotherapy and Radiooncology, OncoRay - National Center for Radiation Research in Oncology, National Center for Tumor Diseases Dresden, University Hospital Carl Gustav Carus Dresden, German Cancer Research Center (DKFZ), Helmholtz-Zentrum Dresden-Rossendorf (HZDR), German Cancer Consortium (DKTK) Partner Site Dresden (Author)
  • Jörg van den Hoff - , Helmholtz-Zentrum Dresden-Rossendorf (HZDR) (Author)
  • Volker Budach - , Charité – Universitätsmedizin Berlin (Author)
  • Jörg Kotzerke - , OncoRay - National Center for Radiation Research in Oncology, Department of Nuclear Medicine, German Cancer Research Center (DKFZ), University Hospital Carl Gustav Carus Dresden, German Cancer Consortium (DKTK) Partner Site Dresden (Author)
  • Konstantinos Ferentinos - , European University Cyprus (Author)
  • Efstratios Karagiannis - , European University Cyprus (Author)
  • David Kaul - , Charité – Universitätsmedizin Berlin (Author)
  • Vincent Gregoire - , Leon Bérard Cancer Center (Author)
  • Adrien Holzgreve - , University Hospital Münster (Author)
  • Nathalie L Albert - , University Hospital Münster (Author)
  • Pavel Nikulin - , Helmholtz-Zentrum Dresden-Rossendorf (HZDR) (Author)
  • Michael Bachmann - , Department of Radiotherapy and Radiooncology, OncoRay - National Center for Radiation Research in Oncology, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) Partner Site Dresden (Author)
  • Klaus Kopka - , Chair of Bioinorganic and Radiopharmaceutical Chemistry, Helmholtz-Zentrum Dresden-Rossendorf (HZDR) (Author)
  • Mechthild Krause - , OncoRay - National Center for Radiation Research in Oncology, Department of Radiotherapy and Radiooncology, University Hospital Carl Gustav Carus Dresden, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) Heidelberg, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), German Cancer Consortium (DKTK) Partner Site Dresden (Author)
  • Michael Baumann - , Department of Radiotherapy and Radiooncology, OncoRay - National Center for Radiation Research in Oncology, University Hospital Carl Gustav Carus Dresden, German Cancer Research Center (DKFZ), Helmholtz-Zentrum Dresden-Rossendorf (HZDR), German Cancer Consortium (DKTK) Partner Site Dresden, German Center for Neurodegenerative Diseases (DZNE) - Partner Site Dresden (Author)
  • Joanna Kazmierska - , Capital Medical University (CMU) (Author)
  • Paulina Cegla - , Greater Poland Cancer Centre (Author)
  • Witold Cholewinski - , Capital Medical University (CMU) (Author)
  • Iosif Strouthos - , European University Cyprus (Author)
  • Klaus Zöphel - , Department of Nuclear Medicine, OncoRay - National Center for Radiation Research in Oncology, Klinikum Chemnitz gGmbH, German Cancer Consortium (DKTK) Partner Site Dresden (Author)
  • Ewa Majchrzak - , University of Medical Sciences Poznan (Author)
  • Guillaume Landry - , University Hospital Münster (Author)
  • Claus Belka - , University Hospital Münster (Author)
  • Carmen Stromberger - , Charité – Universitätsmedizin Berlin (Author)
  • Frank Hofheinz - , Helmholtz-Zentrum Dresden-Rossendorf (HZDR) (Author)

Abstract

PURPOSE: 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is utilized for staging and treatment planning of head and neck squamous cell carcinomas (HNSCC). Some older publications on the prognostic relevance showed inconclusive results, most probably due to small study sizes. This study evaluates the prognostic and potentially predictive value of FDG-PET in a large multi-center analysis.

METHODS: Original analysis of individual FDG-PET and patient data from 16 international centers (8 institutional datasets, 8 public repositories) with 1104 patients. All patients received curative intent radiotherapy/chemoradiation (CRT) and pre-treatment FDG-PET imaging. Primary tumors were semi-automatically delineated for calculation of SUVmax, SUVmean, metabolic tumor volume (MTV) and total lesion glycolysis (TLG). Cox regression analyses were performed for event-free survival (EFS), overall survival (OS), loco-regional control (LRC) and freedom from distant metastases (FFDM).

RESULTS: FDG-PET parameters were associated with patient outcome in the whole cohort regarding clinical endpoints (EFS, OS, LRC, FFDM), in uni- and multivariate Cox regression analyses. Several previously published cut-off values were successfully validated. Subgroup analyses identified tumor- and human papillomavirus (HPV) specific parameters. In HPV positive oropharynx cancer (OPC) SUVmax was well suited to identify patients with excellent LRC for organ preservation. Patients with SUVmax of 14 or less were unlikely to develop loco-regional recurrence after definitive CRT. In contrast FDG PET parameters deliver only limited prognostic information in laryngeal cancer.

CONCLUSION: FDG-PET parameters bear considerable prognostic value in HNSCC and potential predictive value in subgroups of patients, especially regarding treatment de-intensification and organ-preservation. The potential predictive value needs further validation in appropriate control groups. Further research on advanced imaging approaches including radiomics or artificial intelligence methods should implement the identified cut-off values as benchmark routine imaging parameters.

Details

Original languageEnglish
Article number870319
JournalFrontiers in oncology
Volume12
Publication statusPublished - 8 Jun 2022
Peer-reviewedYes

External IDs

PubMedCentral PMC9213669
Scopus 85133387928
ORCID /0000-0003-1776-9556/work/171065757

Keywords

Sustainable Development Goals